FINECARE™ Β-HCG RAPID QUANTITATIVE TEST
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.·Registered October 24, 2018LA PRUEBA CUANTITATIVA RÁPIDA DE Β-HCG DE THE FINECARETM ES UN INMUNOENSAYO DE FLUORESCENCIA UTILIZADO JUNTO CON EL SISTEMA FIA FINECARETM, PARA LA DETERMINACIÓN CUANTITATIVA DE Β-HCG EN SANGRE COMPLETA HUMANA, SUERO O PLASMA. SOLO PARA USO EN E
THE FINECARETM RAPID QUANTITATIVE Β-HCG TEST IS A FLUORESCENCE IMMUNOASSAY USED IN CONJUNCTION WITH THE FINECARETM FIA SYSTEM, FOR THE QUANTITATIVE DETERMINATION OF Β-HCG IN HUMAN WHOLE BLOOD, SERUM OR PLASMA. FOR USE IN E ONLY
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- CARTUCHO DE PRUEBA PARA LA CUANTIFICACION DE Β-HCG
- Trade Name (English)
- TEST CARTRIDGE FOR QUANTIFICATION OF Β-HCG
- Analysis ID
- 2446R2018 SSA
- Registration Date
- October 24, 2018
- Name (Spanish)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
- Name (English)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
Access comprehensive regulatory information for FINECARE™ Β-HCG RAPID QUANTITATIVE TEST (FINECARE™ Β-HCG RAPID QUANTITATIVE TEST) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2446R2018 SSA and manufactured by DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.. The device was registered on October 24, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.